Europe Percutaneous Mechanical Circulatory Support Devices Market Analysis by 2027
Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027Europe Percutaneous Mechanical Circulatory Support Devices Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Product (Intra-Aortic Balloon Pumps, VA-Extracorporeal Membrane Oxygenators (ECMO), and Short-Term Ventricular Assist Devices); End User (Hospitals, Ambulatory Surgical Centers, and Others); and Country
- Report Date : Jan 2021
- Report Code : TIPRE00018223
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 107
The Europe percutaneous mechanical circulatory support devicesmarketis expected to reach US$ 1,199.73 million by 2027 from US$ 456.23 million in 2019;it is estimated to grow at a CAGR of 13.1% from 2020 to 2027.
Therising geriatric population, increasing prevalence of cardiovascular diseases and shortage of heart donorsare the key factors driving the growth of percutaneous mechanical circulatory support devices. However,high costs of these devices and procedures associated with them as well as product recalls, and impact of COVID-19 pandemic on medical device industryis the major factor hindering the market growth in Europe.
Percutaneous mechanical circulatory support devices market offers an effective and rapid approach to slow the downward spiral of hemodynamic instability among patients suffering with decompensated heart failures and cardiogenic shocks till a more definitive strategy is perceived among patients to recover from these cardiac ailments. The major roles of the percutaneous mechanical circulatory support devices include improving the native cardiac output, reducing ventricular volume and filling pressures, augmenting coronary perfusion, and maintaining vital organ perfusion.
Heart disease is the leading cause of death for people in Europe. According to the Centers for Disease Control and Prevention (CDC), in 2016 Cardiovascular disease (CVD) causes more than half of all deaths across the European Union Region. CVD causes 46 times the number of deaths and 11 times the disease burden caused by AIDS, malaria and tuberculosis combined in Europe. 80% of premature heart disease and stroke is preventable in natrure. The Centers for Disease Control and Prevention (CDC) reports that about half of people who develop heart failure die within five years of diagnosis.
Various research studies show that improvements and experience with percutaneous mechanical circulatory support may offer the prospect of better outcomes. Thus, the high prevalence of cardiovascular diseases that majorly includes heart failure conditions rising across European region to which mechanical circulatory devices have emerged as potential solutions for patients’ treatment is likely to boost the growth of the percutaneous mechanical circulatory support devices market.
The chronic shortage of heart donors has also led to extend the age limits of donors in certain areas. Thus, the solution to this shortage of heart donors served by the temporarily used percutaneous mechanical circulatory support devices that are also helpful in long-term support for patients suffering from heart failures is likely to be adopted at higher rates in the coming years.
Among all European countries, Spain, Italy, Germany, France, and the UK are most affected due to the increasing number of COVID-19 cases and deaths associated with it. For instance, the outbreak of the COVID-19 pandemic across the in Germany and Spain has resulted in the frozen production of various medical devices. As various hospitals and healthcare organizations are struggling with the spread of disease, various medical device companies have diverted their focus in producing personal protection equipment. Therefore, it expected that the market for the percutaneous mechanical circulatory support devices would witness slow growth in the coming one or two years.
Rest of Europe Percutaneous Mechanical Circulatory Support DevicesMarket,Revenue and Forecast to 2027 (US$ Mn)
EUROPEPERCUTANEOUS MECHANICAL CIRCULATORY SUPPORT DEVICES MARKET SEGMENTATION
By Product
- Intra-Aortic Balloon Pumps
- VA-Extracorporeal Membrane Oxygenation (ECMO)
- Short-Term Ventricular Assist Devices (VADs)
- Impella
- Tandem Heart
By End User
- Hospitals
- Ambulatory Surgical Centers
- Others
By Country
- Germany
- UK
- France
- Italy
- Spain
Company Profiles
- Getinge AB
- Livanova Plc (Cardiacassist, Inc)
- Eurosets
- Berlin Heart
- CardiobridgeGmbh
- Medtronic
Europe Percutaneous Mechanical Circulatory Support Devices Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 456.23 Million |
| Market Size by 2027 | US$ 1,199.73 Million |
| Global CAGR (2020 - 2027) | 13.1% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
Market Research & Consulting
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA, MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
Yukihiko Adachi CEO, Deep Blue, LLC.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Strategic Planning
- Investment Justification
- Identifying Emerging Markets
- Enhancing Marketing Strategies
- Boosting Operational Efficiency
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- Getinge AB
- Livanova Plc (Cardiacassist, Inc)
- Eurosets
- Berlin Heart
- CardiobridgeGmbh
- Medtronic
Get Free Sample For